These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9860801)

  • 1. Extended mortality benefit of early postinfarction reperfusion.
    Rawles J
    Circulation; 1998 Dec 22-29; 98(25):2934-5. PubMed ID: 9860801
    [No Abstract]   [Full Text] [Related]  

  • 2. [Fibrinolysis therapy using APSAC in acute myocardial infarct].
    Hochrein H
    Dtsch Med Wochenschr; 1990 Jun; 115(25):999. PubMed ID: 2193790
    [No Abstract]   [Full Text] [Related]  

  • 3. [Physiopathologic basis of the use of thrombolytic agents during the acute phase of myocardial infarction].
    Castaigne A; Duval-Moulin AM; Dubois-Randé JL; Merlet P
    Arch Mal Coeur Vaiss; 1989 Oct; 82 Spec No 3():15-20. PubMed ID: 2512883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study of survival using anistreplase (Eminase)].
    Murray RG
    Arch Mal Coeur Vaiss; 1990 Feb; 83 Spec No 1():37-40. PubMed ID: 2108645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombolysis for acute myocardial infarction: drug review.
    Cundiff DK
    MedGenMed; 2002 Jan; 4(1):1. PubMed ID: 11965203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Thrombolytic treatment of acute myocardial infarct. 1].
    Soares-Costa JT; Soares-Costa TJ; Gabriel HM
    Acta Med Port; 1998 May; 11(5):409-19. PubMed ID: 9951051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short- and long-term comparative study of anistreplase versus streptokinase in acute myocardial infarction.
    Silber H; Hausmann MJ; Katz A; Gilutz H; Zucker N; Ovsyshcher I
    Angiology; 1992 Jul; 43(7):572-7. PubMed ID: 1626735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin after thrombolysis for MI.
    Seaton TL
    J Fam Pract; 1997 Mar; 44(3):249-50. PubMed ID: 9071241
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of the predictive value of ST segment elevation resolution at 90 and 180 min after start of streptokinase in acute myocardial infarction. A substudy of the hirudin for improvement of thrombolysis (HIT)-4 study.
    Schröder R; Zeymer U; Wegscheider K; Neuhaus KL
    Eur Heart J; 1999 Nov; 20(21):1563-71. PubMed ID: 10529324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute myocardial infarction: treatment with thrombolytic therapy.
    Topol EJ
    Cardiol Clin; 1989 Nov; 7(4):827-36. PubMed ID: 2688884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the nurse in thrombolytic therapy.
    Albarran J; Kapeluch H
    Br J Nurs; 1994 Feb 10-23; 3(3):104-9. PubMed ID: 8148624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enoxaparin versus unfractionated heparin as antithrombin therapy in patients receiving fibrinolysis for ST-elevation myocardial infarction. Design and rationale for the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25).
    Antman EM; Morrow DA; McCabe CH; Jiang F; White HD; Fox KA; Sharma D; Chew P; Braunwald E;
    Am Heart J; 2005 Feb; 149(2):217-26. PubMed ID: 15846258
    [No Abstract]   [Full Text] [Related]  

  • 13. An early invasive strategy versus ischemia-guided management after fibrinolytic therapy for ST-segment elevation myocardial infarction: a meta-analysis of contemporary randomized controlled trials.
    Wijeysundera HC; You JJ; Nallamothu BK; Krumholz HM; Cantor WJ; Ko DT
    Am Heart J; 2008 Sep; 156(3):564-572, 572.e1-2. PubMed ID: 18760142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Reperfusion after acute myocardial infarct with fibrinolytic therapy o combination reduced fibrinolytic therapy and a glycoprotein IIb/IIIa inhibitor: the GUSTO V study].
    Franzosi MG
    Ital Heart J Suppl; 2001 Sep; 2(9):1034-6. PubMed ID: 11675828
    [No Abstract]   [Full Text] [Related]  

  • 15. Quantification of the benefit of earlier thrombolytic therapy: five-year results of the Grampian Region Early Anistreplase Trial (GREAT).
    Rawles JM
    J Am Coll Cardiol; 1997 Nov; 30(5):1181-6. PubMed ID: 9350912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombolysis-associated ventricular fibrillation: is it reperfusion, the drug or what?
    Verheugt FW
    Eur Heart J; 1996 Feb; 17(2):172-3. PubMed ID: 8732368
    [No Abstract]   [Full Text] [Related]  

  • 17. Ventricular fibrillation following administration of thrombolytic treatment. The EMIP experience. European Myocardial Infarction Project.
    Boissel JP; Castaigne A; Mercier C; Lion L; Leizorovicz A
    Eur Heart J; 1996 Feb; 17(2):213-21. PubMed ID: 8732374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of perfusion data.
    Rapaport E
    Eur Heart J; 1990 Aug; 11 Suppl F():10-4. PubMed ID: 2121487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Happy birthday, GISSI!
    Braunwald E
    Am Heart J; 2004 Aug; 148(2):187. PubMed ID: 15308983
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacologic reperfusion strategies for the treatment of ST-segment elevation myocardial infarction.
    Young JJ; Kereiakes DJ
    Rev Cardiovasc Med; 2003; 4(4):216-27. PubMed ID: 14668689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.